News

The promise of the first new Alzheimer’s drug in nearly 2 decades

Welcome to Business Insider ‘ s daily healthcare newsletter , your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hello, While we wait to hear more about the results of the presidential election, here’s the latest in healthcare news. […]
The promise of the first new Alzheimer’s drug in nearly 2 decades
News

Trump calls for the FDA to approve one of the COVID-19 treatments he got

Welcome to Business Insider ‘ s daily healthcare newsletter , your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hello, Happy Thursday! Everyone might be buzz-ing about the vice presidential debate (get it?), but there’s plenty of healthcare updates […]
Trump calls for the FDA to approve one of the COVID-19 treatments he got
News

What you need to know about GoodRx’s plans to go public

Welcome to Dispensed Daily , your daily dose of healthcare news from Business Insider’s healthcare editor Lydia Ramsey Pflanzer and the healthcare team. Subscribe here to get this newsletter in your inbox every weekday. Hello, Welcome to Dispensed, Business Insider’s healthcare newsletter. I’m Megan Hernbroth, the most recent addition to […]
What you need to know about GoodRx’s plans to go public
News

A top executive at one of America’s largest healthcare companies is leaving for the rest of the year to go help the WHO develop a coronavirus vaccine

Andrew Witty, the president of health giant UnitedHealth Group and CEO of its Optum unit, is taking a leave of absence to lead the World Health Organisation’s efforts to develop a coronavirus vaccine, UnitedHealth said on Wednesday. Prior to running Optum, Witty was CEO of pharma company GlaxoSmithKline, which has […]
A top executive at one of America’s largest healthcare companies is leaving for the rest of the year to go help the WHO develop a coronavirus vaccine
News

Dispensed: Ancestry’s big move into healthcare, digital health’s disruption of addiction treatment, and investors’ multi-billion-dollar bet on the microbiome

Hello, Welcome to another edition of Dispensed, the weekly healthcare newsletter where we’re busy compiling names for our DC power-players post (if you haven’t submitted a name, now’s your chance!). On this brisk autumn day, we’ll get right to the stories that filled our minds this week. But first, Are […]
Dispensed: Ancestry’s big move into healthcare, digital health’s disruption of addiction treatment, and investors’ multi-billion-dollar bet on the microbiome
News

Congress grilled little-known middlemen over the high cost of prescription drugs. Here’s how they defended themselves.

In February, Congress brought in a group of pharmaceutical CEOs and executives from seven companies to testify about the high price of prescription drugs. On Tuesday, Congress kept the conversation going, this time grilling pharmacy benefit managers, the little-known middlemen responsible for negotiating drug prices. During the hearing executives from […]
Congress grilled little-known middlemen over the high cost of prescription drugs. Here’s how they defended themselves.